PRAZOSIN HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for prazosin hydrochloride and what is the scope of patent protection?
Prazosin hydrochloride
is the generic ingredient in three branded drugs marketed by Pfizer, Alembic, Am Therap, Ani Pharms, Appco, Aurobindo Pharma Ltd, Dava Pharms Inc, Granules, Lannett Co Inc, Mankind Pharma, MSN, Mylan, Novitium Pharma, Purepac Pharm, Teva Pharms, and Watson Labs, and is included in twenty-five NDAs. Additional information is available in the individual branded drug profile pages.There are fourteen drug master file entries for prazosin hydrochloride. Thirty suppliers are listed for this compound.
Summary for PRAZOSIN HYDROCHLORIDE
| US Patents: | 0 |
| Tradenames: | 3 |
| Applicants: | 16 |
| NDAs: | 25 |
| Drug Master File Entries: | 14 |
| Finished Product Suppliers / Packagers: | 30 |
| Raw Ingredient (Bulk) Api Vendors: | 117 |
| Clinical Trials: | 67 |
| Patent Applications: | 2,629 |
| What excipients (inactive ingredients) are in PRAZOSIN HYDROCHLORIDE? | PRAZOSIN HYDROCHLORIDE excipients list |
| DailyMed Link: | PRAZOSIN HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for PRAZOSIN HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Kinnov Therapeutics | Phase 1 |
| The Royal's Institute of Mental Health Research | Early Phase 1 |
| Ottawa Hospital Research Institute | Early Phase 1 |
Pharmacology for PRAZOSIN HYDROCHLORIDE
| Drug Class | alpha-Adrenergic Blocker |
| Mechanism of Action | Adrenergic alpha-Antagonists |
Medical Subject Heading (MeSH) Categories for PRAZOSIN HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for PRAZOSIN HYDROCHLORIDE
US Patents and Regulatory Information for PRAZOSIN HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novitium Pharma | PRAZOSIN HYDROCHLORIDE | prazosin hydrochloride | CAPSULE;ORAL | 210971-001 | Oct 3, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Watson Labs | PRAZOSIN HYDROCHLORIDE | prazosin hydrochloride | CAPSULE;ORAL | 072609-001 | May 16, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Granules | PRAZOSIN HYDROCHLORIDE | prazosin hydrochloride | CAPSULE;ORAL | 214608-003 | Dec 23, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Purepac Pharm | PRAZOSIN HYDROCHLORIDE | prazosin hydrochloride | CAPSULE;ORAL | 072921-001 | May 16, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Appco | PRAZOSIN HYDROCHLORIDE | prazosin hydrochloride | CAPSULE;ORAL | 213406-001 | Oct 21, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Appco | PRAZOSIN HYDROCHLORIDE | prazosin hydrochloride | CAPSULE;ORAL | 213406-002 | Oct 21, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Am Therap | PRAZOSIN HYDROCHLORIDE | prazosin hydrochloride | CAPSULE;ORAL | 072782-001 | May 16, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PRAZOSIN HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Pfizer | MINIPRESS | prazosin hydrochloride | CAPSULE;ORAL | 017442-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Pfizer | MINIPRESS XL | prazosin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 019775-002 | Jan 29, 1992 | ⤷ Sign Up | ⤷ Sign Up |
| Pfizer | MINIPRESS XL | prazosin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 019775-001 | Jan 29, 1992 | ⤷ Sign Up | ⤷ Sign Up |
| Pfizer | MINIPRESS | prazosin hydrochloride | CAPSULE;ORAL | 017442-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Pfizer | MINIPRESS | prazosin hydrochloride | CAPSULE;ORAL | 017442-003 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Pfizer | MINIPRESS XL | prazosin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 019775-002 | Jan 29, 1992 | ⤷ Sign Up | ⤷ Sign Up |
| Pfizer | MINIPRESS XL | prazosin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 019775-002 | Jan 29, 1992 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
